These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2558829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
    Anastassiades E, Ireland H, Flynn A, Lane DA, Curtis JR.
    Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
    [Abstract] [Full Text] [Related]

  • 3. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis.
    Ryan KE, Lane DA, Flynn A, Shepperd J, Ireland HA, Curtis JR.
    Thromb Haemost; 1991 Sep 02; 66(3):277-82. PubMed ID: 1745997
    [Abstract] [Full Text] [Related]

  • 4. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222.
    Ireland H, Lane DA, Flynn A, Pegrum AC, Curtis JR.
    Thromb Haemost; 1988 Apr 08; 59(2):240-7. PubMed ID: 2838924
    [Abstract] [Full Text] [Related]

  • 5. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model.
    Ao PY, Hawthorne WJ, Coombs R, Fletcher JP.
    Int Angiol; 1999 Jun 08; 18(2):131-9. PubMed ID: 10424369
    [Abstract] [Full Text] [Related]

  • 6. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
    Lane DA, Ireland H, Flynn A, Anastassiades E, Curtis JR.
    Nephrol Dial Transplant; 1986 Jun 08; 1(3):179-87. PubMed ID: 2955253
    [Abstract] [Full Text] [Related]

  • 7. Heparin induces mobilization of osteoprotegerin into the circulation.
    Vik A, Brodin E, Sveinbjørnsson B, Hansen JB.
    Thromb Haemost; 2007 Jul 08; 98(1):148-54. PubMed ID: 17598007
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic and pharmacodynamic characterization of a medium-molecular-weight heparin in comparison with UFH and LMWH.
    Alban S, Welzel D, Hemker HC.
    Semin Thromb Hemost; 2002 Aug 08; 28(4):369-78. PubMed ID: 12244484
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S, Wolz M, Nieszpaur-Los M, Schneider B, Lechner K, Eichler HG, Kyrle PA.
    Thromb Haemost; 1994 Dec 08; 72(6):831-5. PubMed ID: 7740450
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction.
    Nilsen DW, Gøransson L, Larsen AI, Hetland O, Kierulf P.
    Thromb Haemost; 1997 Jan 08; 77(1):57-61. PubMed ID: 9031450
    [Abstract] [Full Text] [Related]

  • 16. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
    Gunnarsson B, Asaba H, Dawidson S, Wilhelmsson S, Bergström J.
    Clin Nephrol; 1981 Mar 08; 15(3):135-42. PubMed ID: 7273488
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin.
    Camici M, Giordani R, Morelli E, Meriggioli M, Balestri PL, Barsotti G, Sagripanti A.
    Minerva Med; 1998 Mar 08; 89(11-12):405-9. PubMed ID: 10212664
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of low molecular weight heparin during and after aortic and carotid surgery: dose finding study.
    Alimi YS, Juhan C, Barthelemy P, Boudier JL, Pansart M, Boutin B, De Moro S.
    Panminerva Med; 1996 Mar 08; 38(1):15-21. PubMed ID: 8766874
    [Abstract] [Full Text] [Related]

  • 20. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
    Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G.
    Arch Intern Med; 2007 Dec 10; 167(22):2423-30. PubMed ID: 18071163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.